TD Cowen analyst Andrew Kligerman maintained a Buy rating on Arch Capital Group (ACGL – Research Report) today and set a price target of ...

TD Cowen analyst Ritu Baral reiterated a Buy rating on Vera Therapeutics (VERA – Research Report) yesterday and set a price target of $60.00.

EIR analyst Dittmar called the deal a priority for Diamondback “because it represents one of the last current opportunities ...

CNBC’s Eamon Javers and TD Cowen’s Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense ...

TD Cowen adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, raising the price target from $300.00 to $305.00.

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...

Rion Aesthetics, a company at the forefront of exosome technology in the aesthetics industry, today announced its ...

Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...

Management will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company's website, https ...

TD Securities’ purchase of Cowen brought together balance sheet strength with the high-touch investment banking needed to service client growth. For building a combined platform that is greater than ...

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website ...